- Home
- SEER vs NAUT Comparison
SEER vs NAUT Comparison
Compare SEER & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- NAUT
- Stock Information
- Founded
- SEER 2017
- NAUT 2016
- Country
- SEER United States
- NAUT United States
- Employees
- SEER N/A
- NAUT N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- SEER Health Care
- NAUT Industrials
- Exchange
- SEER Nasdaq
- NAUT Nasdaq
- Market Cap
- SEER 113.8M
- NAUT 95.6M
- IPO Year
- SEER 2020
- NAUT N/A
- Fundamental
- Price
- SEER $2.05
- NAUT $0.72
- Analyst Decision
- SEER
- NAUT Strong Sell
- Analyst Count
- SEER 0
- NAUT 1
- Target Price
- SEER N/A
- NAUT $1.75
- AVG Volume (30 Days)
- SEER 137.3K
- NAUT 252.3K
- Earning Date
- SEER 11-05-2025
- NAUT 10-28-2025
- Dividend Yield
- SEER N/A
- NAUT N/A
- EPS Growth
- SEER N/A
- NAUT N/A
- EPS
- SEER N/A
- NAUT N/A
- Revenue
- SEER $16,288,000.00
- NAUT N/A
- Revenue This Year
- SEER $27.77
- NAUT N/A
- Revenue Next Year
- SEER $20.28
- NAUT N/A
- P/E Ratio
- SEER N/A
- NAUT N/A
- Revenue Growth
- SEER 10.52
- NAUT N/A
- 52 Week Low
- SEER $1.61
- NAUT $0.62
- 52 Week High
- SEER $2.63
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- SEER 47.32
- NAUT 54.09
- Support Level
- SEER $1.97
- NAUT $0.70
- Resistance Level
- SEER $2.10
- NAUT $0.73
- Average True Range (ATR)
- SEER 0.05
- NAUT 0.04
- MACD
- SEER 0.00
- NAUT 0.01
- Stochastic Oscillator
- SEER 50.00
- NAUT 77.46
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.